TipRanks
Advertisement
Advertisement

HK:2268 Stock Latest News

WuXi XDC Grants Restricted Shares to Employees Under 2024 Incentive Scheme
Company AnnouncementsWuXi XDC Grants Restricted Shares to Employees Under 2024 Incentive Scheme
1M ago
2268
WuXi XDC Delivers Strong Interim Growth but Withholds Interim Dividend
PremiumCompany Announcements
WuXi XDC Delivers Strong Interim Growth but Withholds Interim Dividend
1M ago
2268
WuXi XDC to Present 2026 Interim Results via Dual-Language Investor Calls
PremiumCompany Announcements
WuXi XDC to Present 2026 Interim Results via Dual-Language Investor Calls
1M ago
2268
WuXi XDC Schedules Board Meeting to Approve 2026 Interim Results
PremiumCompany Announcements
WuXi XDC Schedules Board Meeting to Approve 2026 Interim Results
3M ago
2268
WuXi XDC appoints joint company secretaries and secures governance waiver
PremiumCompany Announcements
WuXi XDC appoints joint company secretaries and secures governance waiver
3M ago
2268
WuXi XDC Shareholders Approve All AGM Resolutions, Back Board and Capital Mandates
PremiumCompany AnnouncementsWuXi XDC Shareholders Approve All AGM Resolutions, Back Board and Capital Mandates
3M ago
2268
WuXi XDC Unit BioDlink Signs RMB19 Million Monoclonal Antibody Manufacturing Deal With WuXi Biologics
Premium
Company Announcements
WuXi XDC Unit BioDlink Signs RMB19 Million Monoclonal Antibody Manufacturing Deal With WuXi Biologics
3M ago
2268
WuXi XDC Sets 2026 AGM to Renew Capital-Issuance Mandate
Premium
Company Announcements
WuXi XDC Sets 2026 AGM to Renew Capital-Issuance Mandate
4M ago
2268
WuXi XDC Buys HK$326.5 Million in Shares for Incentive Schemes
PremiumCompany Announcements
WuXi XDC Buys HK$326.5 Million in Shares for Incentive Schemes
4M ago
2268
WuXi XDC allocates up to US$100 million for on‑market share purchases
PremiumCompany Announcements
WuXi XDC allocates up to US$100 million for on‑market share purchases
4M ago
2268
WuXi XDC Grants 4.85 Million Restricted Shares Under 2024 Incentive Scheme
PremiumCompany Announcements
WuXi XDC Grants 4.85 Million Restricted Shares Under 2024 Incentive Scheme
6M ago
2268
WuXi XDC Cash Offers Close With Offeror Gaining Majority Control
PremiumCompany Announcements
WuXi XDC Cash Offers Close With Offeror Gaining Majority Control
6M ago
2268
WuXi XDC: Strong Execution, Capacity Expansion and Robust Growth Outlook Support Maintained Buy Rating
PremiumRatingsWuXi XDC: Strong Execution, Capacity Expansion and Robust Growth Outlook Support Maintained Buy Rating
6M ago
WuXi XDC Posts Strong 2025 Profit Growth but Withholds Final Dividend
Premium
Company Announcements
WuXi XDC Posts Strong 2025 Profit Growth but Withholds Final Dividend
6M ago
2268
WuXi XDC to Present 2025 Results in Dual Conference Calls on March 24, 2026
Premium
Company Announcements
WuXi XDC to Present 2025 Results in Dual Conference Calls on March 24, 2026
6M ago
2268
WuXi XDC Cash Offer Turns Unconditional as Offeror Secures Majority Control
PremiumCompany Announcements
WuXi XDC Cash Offer Turns Unconditional as Offeror Secures Majority Control
6M ago
2268
WuXi XDC tender offer reaches 46.5% acceptances, short of control threshold
PremiumCompany Announcements
WuXi XDC tender offer reaches 46.5% acceptances, short of control threshold
7M ago
2268
WuXi XDC Sends Composite Document for Voluntary Cash Offers and Option Cancellation
PremiumCompany Announcements
WuXi XDC Sends Composite Document for Voluntary Cash Offers and Option Cancellation
8M ago
2268
WuXi XDC Delays Dispatch of Composite Document for Voluntary Cash Offers
PremiumCompany Announcements
WuXi XDC Delays Dispatch of Composite Document for Voluntary Cash Offers
8M ago
2268
WuXi XDC Delays Shareholder Circular on Offer Transactions After HKEX Waiver
PremiumCompany AnnouncementsWuXi XDC Delays Shareholder Circular on Offer Transactions After HKEX Waiver
8M ago
2268
WuXi XDC Schedules Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
WuXi XDC Schedules Board Meeting to Approve 2025 Annual Results
8M ago
2268
WuXi XDC: Buy Rating on Accelerating Growth, Capacity Expansion, and Strengthened Competitive Position Post-BioDlink Acquisition
Premium
Ratings
WuXi XDC: Buy Rating on Accelerating Growth, Capacity Expansion, and Strengthened Competitive Position Post-BioDlink Acquisition
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >